Cell-specific targeting by heterobivalent ligands

Bioconjugate Chemistry

Volumn 22, Issue 7, 2011, Pages 1270-1278

  Josan, Jatinder S ^a   Handl, Heather L ^a   Sankaranarayanan, Rajesh ^a   Xu, Liping ^b   Lynch, Ronald M ^c   Vagner, Josef ^c   Mash, Eugene A ^a   Hruby, Victor J ^a,c   Gillies, Robert J ^b  

^a University of Arizona   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CELL MEMBRANES; CYTOLOGY; PEPTIDES;

'CURRENT; CANCER THERAPY; CELL SURFACE RECEPTORS; COMBINATION APPROACHES; GENE PRODUCTS; LIGAND-RECEPTOR; MELANOCORTINS; PEPTIDE LIGAND; PROOF OF CONCEPT; SYNTHETIC BUILDING BLOCKS;

LIGANDS;

CELL SURFACE RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; G PROTEIN COUPLED RECEPTOR; HETEROBIVALENT LIGAND; INTERMEDIN; LIGAND; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

EID: 79960608117     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1004284     Document Type: Article

References (35)

1. Hornick, C. L. and Karush, F. (1972) Antibody affinity. III. The role of multivalance Immunochemistry 9, 325-340
2. Mammen, M., Choi, S.-K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2754-2794 (Pubitemid 29008561)
3. Handl, H. L., Sankaranarayanan, R., Josan, J. S., Vagner, J., Mash, E. A., Gillies, R. J., and Hruby, V. J. (2007) Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R) Bioconjugate Chem. 18, 1101-9 (Pubitemid 47122630)
4. Vagner, J., Handl, H. L., Gillies, R. J., and Hruby, V. J. (2004) Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH Bioorg. Med. Chem. Lett. 14, 211-5 (Pubitemid 38010222)
5. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2006) Synthetic multivalent ligands as probes of signal transduction Angew. Chem., Int. Ed. 45, 2348-2368 (Pubitemid 44105109)
6. Sharma, S. D., Granberry, M. E., Jiang, J., Leong, S. P., Hadley, M. E., and Hruby, V. J. (1994) Multivalent melanotropic peptide and fluorescent macromolecular conjugates: new reagents for characterization of melanotropin receptors Bioconjugate Chem. 5, 591-601
7. Sharma, S. D., Jiang, J., Hadley, M. E., Bentley, D. L., and Hruby, V. J. (1996) Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors Proc. Natl. Acad. Sci. U. S. A. 93, 13715-20 (Pubitemid 26424185)
8. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2000) Synthetic multivalent ligands in the exploration of cell-surface interactions Curr. Opin. Chem. Biol. 4, 696-703
9. Ghaghada, K. B., Saul, J., Natarajan, J. V., Bellamkonda, R. V., and Annapragada, A. V. (2005) Folate targeting of drug carriers: a mathematical model J. Controlled Release 104, 113-28 (Pubitemid 40615240)
10. Saul, J. M., Annapragada, A., Natarajan, J. V., and Bellamkonda, R. V. (2003) Controlled targeting of liposomal doxorubicin via the folate receptor in vitro J. Controlled Release 92, 49-67 (Pubitemid 37130121)
11. Caplan, M. R. and Rosca, E. V. (2005) Targeting drugs to combinations of receptors: a modeling analysis of potential specificity Ann. Biomed. Eng. 33, 1113-24 (Pubitemid 41165014)
12. Gillies, R. J. and Hruby, V. J. (2003) Expression-driven reverse engineering of targeted imaging and therapeutic agents Expert Opin. Ther. Targets 7, 137-9 (Pubitemid 36512015)
13. Balagurunathan, Y., Morse, D. L., Hostetter, G., Shanmugam, V., Stafford, P., Shack, S., Pearson, J., Trissal, M., Demeure, M. J., Von Hoff, D. D., Hruby, V. J., Gillies, R. J., and Han, H. (2008) Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer Mol. Cancer. Ther. 7, 3071-80
14. Vagner, J., Xu, L., Handl, H. L., Josan, J. S., Morse, D. L., Mash, E. A., Gillies, R. J., and Hruby, V. J. (2008) Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors Angew. Chem., Int. Ed. 47, 1685-8
15. We have coined the term "lanthaligand" to denote a lanthanide chelate labeled ligand. See Josan, J. S. (2008) Heteromultivalent ligands directed targeting of cell-surface receptors-Implications in cancer diagnostics & therapeutics, Ph.D. Thesis, The University of Arizona, Tucson.
16. Josan, J. S., Vagner, J., Handl, H. L., Sankaranarayanan, R., Gillies, R. J., and Hruby, V. J. (2008) Solid-phase synthesis of heterobivalent ligands targeted to melanocortin and cholecystokinin receptors Int. J. Pept. Res. Ther. 14, 293-300
17. Mohamadi, F., Richards, N. G. J., Guida, W. C., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T., and Still, W. C. (1990) Macromodel-an integrated software system for modeling organic and bioorganic molecules using molecular mechanics J. Comput. Chem. 11, 440-467
18. Li, J., Edwards, P., Burghammer, M., Villa, C., and Schertler, G. (2004) Structure of bovine rhodopsin in a trigonal crystal form J. Mol. Biol. 343, 1409-1438 (Pubitemid 39387834)
19. Xu, L., Vagner, J., Josan, J. S., Lynch, R. M., Morse, D. L., Baggett, B., Han, H., Mash, E. A., Hruby, V. J., and Gillies, R. J. (2009) Enhanced targeting with heterobivalent ligands Mol. Cancer Ther. 8, 2356-2365
20. Handl, H. L., Vagner, J., Yamamura, H. I., Hruby, V. J., and Gillies, R. J. (2004) Lanthanide-based time-resolved fluorescence of in cyto ligand - receptor interactions Anal. Biochem. 330, 242-250 (Pubitemid 38760098)
21. Handl, H. L. and Gillies, R. J. (2005) Lanthanide-based luminescent assays for ligand-receptor interactions Life Sci. 77, 361-371 (Pubitemid 40719218)
22. Carnie, S., Israelachvili, J. N., and Pailthorpe, B. A. (1979) Lipid packing and transbilayer asymmetries of mixed lipid vesicles Biochim. Biophys. Acta 554, 340-57 (Pubitemid 9234255)
23. Hadac, E. M., Ji, Z., Pinon, D. I., Henne, R. M., Lybrand, T. P., and Miller, L. J. (1999) A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely J. Med. Chem. 42, 2105-11 (Pubitemid 29284230)
24. Fourmy, D., Escrieut, C., Archer, E., Galès, C., Gigoux, V., Maigret, B., Moroder, L., Silvente-Poirot, S., Martinez, J., Fehrentz, J. A., and Pradayrol, L. (2002) Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists Pharmacol. Toxicol. 91, 313-20 (Pubitemid 36132436)
25. Handl, H. L., Vagner, J., Han, H., Mash, E. A., Hruby, V. J., and Gillies, R. J. (2004) Hitting multiple targets with multimeric ligands Expert Opin. Ther. Targets 8, 565-86 (Pubitemid 40028367)
26. Vagner, J., Handl, H. L., Monguchi, Y., Jana, U., Begay, L. J., Mash, E. A., Hruby, V. J., and Gillies, R. J. (2006) Rigid linkers for bioactive peptides Bioconjugate Chem. 17, 1545-50 (Pubitemid 44851501)
27. Ladokhin, A. S., Selsted, M. E., and White, S. H. (1999) CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix Biochemistry 38, 12313-12319
28. Reubi, J. C., Waser, B., Schaer, J. C., Laederach, U., Erion, J., Srinivasan, A., Schmidt, M. A., and Bugaj, J. E. (1998) Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo Eur. J. Nucl. Med. 25, 481-490 (Pubitemid 28254592)
29. Handl, H. L., Vagner, J., Yamamura, H. I., Hruby, V. J., and Gillies, R. J. (2005) Development of a lanthanide-based assay for detection of receptor - ligand interactions at the δ-opioid receptor Anal. Biochem. 343, 299-307 (Pubitemid 41074044)
30. Huang, J., Dong, L., and Lebreton, G. (2006) Mass-dependent signaling between G protein coupled receptors Cell. Signal 18, 564-576 (Pubitemid 41790376)
31. Portoghese, P. S. (2001) From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes J. Med. Chem. 44, 2259-69 (Pubitemid 32867394)
32. Rao, J., Lahiri, J., Isaacs, L., Weis, R. M., and Whitesides, G. M. (1998) A trivalent system from vancomycin. d Ala- d Ala with higher affinity than avidin.biotin Science 280, 708-11 (Pubitemid 28243338)
33. Shrivastava, A., Von Wronski, M., Sato, A., Dransfield, D., Sexton, D., Bogdan, N., Pillai, R., Nanjappan, P., Song, B., Marinelli, E., Deoliveira, D., Luneau, C., Devlin, M., Muruganandam, A., Abujoub, A., Connelly, G., Wu, Q., Conley, G., Chang, Q., Tweedle, M., Ladner, R., Swenson, R., and Nunn, A. (2005) A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases Protein Eng. Des. Sel. 18, 417-424 (Pubitemid 41219888)
34. Carrithers, M. D. and Lerner, M. R. (1996) Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors Chem. Biol. 3, 537-42 (Pubitemid 26324166)
35. Zheng, Y., Akgün, E., Harikumar, K. G., Hopson, J., Powers, M. D., Lunzer, M. M., Miller, L. J., and Portoghese, P. S. (2009) Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK 2) Receptors by Novel Bivalent Ligands J. Med. Chem. 52, 247-258